3878.T

The company's capital structure is characterized by a debt-to-equity ratio of 0.91, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.19, suggesting it can cover short-term obligations but with limited surplus. The company's price-to-book ratio of 0.57 implies that the market values the company at a discount to its book value, which may reflect concerns about asset quality or future earnings potential.

Profitability metrics show a return on equity (ROE) of 4.93% and a return on assets (ROA) of 1.63%, both of which are below the industry norms for Commodity Chemicals. The company's operating margin is 3.17% (calculated from operating income of ¥1,092 million on revenue of ¥34,432 million), which is also below the median for the industry. These figures suggest the company is underperforming in terms of generating returns relative to its peers.

The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification may expose the company to higher operational and market risks, particularly in the volatile chemical industry. The absence of segment or geographic breakdowns limits the ability to assess the resilience of different parts of the business.

Looking ahead, the company's growth trajectory appears modest. Based on the current fiscal year's revenue of ¥34,432 million, the outlook for the next fiscal year is not explicitly provided, but the company's free cash flow of ¥2 million suggests limited capacity for organic growth or reinvestment. The company's capital expenditures of ¥2,669 million were negative, indicating a reduction in investment in physical assets, which may signal a strategic shift or financial constraints.

The company's risk profile includes a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights a potential liquidity challenge. The company's dilution risk is low, with no significant dilution sources identified in the available data. However, the company's capital structure and liquidity position may require close monitoring in the event of a downturn in the chemical industry.

Recent events and disclosures include the latest actual earnings per share (EPS) of ¥72.99 and revenue of ¥34,432 million, as reported in the IR observations. These figures align with the financial snapshot and suggest that the company is meeting analyst expectations in the short term. No recent filings or transcripts are provided in the available data, so the company's strategic direction and operational performance must be inferred from the financial metrics.